77 related articles for article (PubMed ID: 7594448)
1. Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line.
Kiefer J; Okret S; Jondal M; McConkey DJ
J Immunol; 1995 Nov; 155(10):4525-8. PubMed ID: 7594448
[TBL] [Abstract][Full Text] [Related]
2. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells.
Ramdas J; Liu W; Harmon JM
Cancer Res; 1999 Mar; 59(6):1378-85. PubMed ID: 10096574
[TBL] [Abstract][Full Text] [Related]
4. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
5. Modulator inhibits nuclear translocation of the glucocorticoid receptor and inhibits glucocorticoid-induced apoptosis in the human leukemic cell line CEM C-7.
Robertson NM; Bodine PV; Hsu TC; Alnemri ES; Litwack G
Cancer Res; 1995 Feb; 55(3):548-56. PubMed ID: 7834624
[TBL] [Abstract][Full Text] [Related]
6. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
7. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down- and up-regulation.
Barrett TJ; Vig E; Vedeckis WV
Biochemistry; 1996 Jul; 35(30):9746-53. PubMed ID: 8703946
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells.
Dong H; Zitt C; Auriga C; Hatzelmann A; Epstein PM
Biochem Pharmacol; 2010 Feb; 79(3):321-9. PubMed ID: 19737543
[TBL] [Abstract][Full Text] [Related]
9. Three mechanisms are involved in glucocorticoid receptor autoregulation in a human T-lymphoblast cell line.
Pedersen KB; Geng CD; Vedeckis WV
Biochemistry; 2004 Aug; 43(34):10851-8. PubMed ID: 15323545
[TBL] [Abstract][Full Text] [Related]
10. Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines.
Pedersen KB; Vedeckis WV
Biochemistry; 2003 Sep; 42(37):10978-90. PubMed ID: 12974633
[TBL] [Abstract][Full Text] [Related]
11. Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis.
Fumarola C; Zerbini A; Guidotti GG
Cell Death Differ; 2001 Oct; 8(10):1004-13. PubMed ID: 11598798
[TBL] [Abstract][Full Text] [Related]
12. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line.
Strasser-Wozak EM; Hattmannstorfer R; Hála M; Hartmann BL; Fiegl M; Geley S; Kofler R
Cancer Res; 1995 Jan; 55(2):348-53. PubMed ID: 7812967
[TBL] [Abstract][Full Text] [Related]
13. TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death.
Zhan Y; Funda DP; Every AL; Fundova P; Purton JF; Liddicoat DR; Cole TJ; Godfrey DI; Brady JL; Mannering SI; Harrison LC; Lew AM
Int Immunol; 2004 Sep; 16(9):1315-21. PubMed ID: 15262900
[TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells.
Jun CD; Pae HO; Yoo JC; Kwak HJ; Park RK; Chung HT
Cell Immunol; 1998 Jan; 183(1):13-21. PubMed ID: 9578715
[TBL] [Abstract][Full Text] [Related]
15. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Catchpoole DR; Stewart BW
Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
[TBL] [Abstract][Full Text] [Related]
16. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression.
Myklebust JH; Josefsen D; Blomhoff HK; Levy FO; Naderi S; Reed JC; Smeland EB
J Cell Physiol; 1999 Jul; 180(1):71-80. PubMed ID: 10362019
[TBL] [Abstract][Full Text] [Related]
17. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells.
Keren-Tal I; Suh BS; Dantes A; Lindner S; Oren M; Amsterdam A
Exp Cell Res; 1995 May; 218(1):283-95. PubMed ID: 7737366
[TBL] [Abstract][Full Text] [Related]
18. cAMP analogs prevent activation-induced apoptosis of T cell hybridomas.
Lee MR; Liou ML; Liou ML; Yang YF; Lai MZ
J Immunol; 1993 Nov; 151(10):5208-17. PubMed ID: 8228219
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.
Powers JH; Hillmann AG; Tang DC; Harmon JM
Cancer Res; 1993 Sep; 53(17):4059-65. PubMed ID: 8358735
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.
Costas M; Trapp T; Pereda MP; Sauer J; Rupprecht R; Nahmod VE; Reul JM; Holsboer F; Arzt E
J Clin Invest; 1996 Sep; 98(6):1409-16. PubMed ID: 8823306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
